查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511908

精準醫療市場規模、佔有率、趨勢分析報告：按應用、按最終用途、按地區、細分市場預測，2024-2030 年

Precision Medicine Market Size, Share & Trends Analysis Report By Application (Diagnostics, Therapeutics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

精準醫療市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球精準醫療市場規模將達到2,492.4億美元，2024年至2030年複合年成長率為16.3%。

引入具有成本效益的基因組和分子生物學測試方法、癌症和罕見疾病盛行率的增加以及巨量資料在精準醫療中的使用不斷增加等趨勢是推動市場成長的一些關鍵因素。

人類基因組計劃引入了令人興奮的最尖端科技，例如全基因組序列測定和靶向序列測定。研究人員使用這些技術來研究基因組並創造治療各種疾病的個人化療法。如今，世界範圍內腫瘤學、免疫學和神經學等領域的疾病盛行率正在迅速增加。

研究人員、醫療保健專業人員以及大型製藥和生物技術公司正在共同努力，為患者健康發現新的治療方法選擇。許多治療方法和藥物目前正在進行臨床試驗以治療各種類型的癌症。此外，研究人員有興趣在癌症以外的疾病領域開發精準醫學和診斷方法。

除了治療之外，診斷領域近年來也經歷了快速成長。次世代定序（NGS）、生物標記、伴同性診斷和深奧測試的使用有可能改變和影響藥物處方模式。個人化藥物很可能在未來20年內取得巨大成功，並有能力治療和治癒少數以前不可能的疾病。

政府和監管機構的參與對該行業的發展發揮著至關重要的作用。 2015年，時美國政府宣布推出精準醫療計畫。隔年，中國推出了中國精準醫療計畫。這是一項為期15年的計劃，旨在使該國成為精準治療發展的領導者。

目前，生物技術和製藥公司改進產品線中超過 40% 的藥物都含有生物標記。該簡報還建議，多家生物製藥公司在過去五年中已經建立了合作和合資企業，預計未來幾年將繼續下去。因此，診斷和治療精準醫學市場潛力巨大，並正在迅速轉變為患者照護的基本領域。

精準醫療市場報告亮點

  • 治療領域將在 2023 年引領市場，預計在預測期內複合年成長率為 15.8%。
  • 至2023年，醫院業將以60.0%的銷售佔有率引領市場。醫院憑藉其完善的基礎設施和接觸不同患者群體的能力，為個人化醫療提供了理想的環境。
  • 2023年北美精準醫療市場佔比53.62%。根據 2022 年 PMC 報告，自 2014 年以來，個人化醫療佔 FDA核准的藥物的四分之一以上。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章精準醫療市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 市場機會分析
  • 精準醫療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 價格分析
    • 定量分析（設備）

第4章精準醫療市場：應用預估與趨勢分析

  • 全球精準醫療市場：應用儀表板
  • 全球精準醫療市場：應用變遷分析
  • 全球精準醫療市場：按應用和收益
  • 診斷
  • 治療

第5章精準醫療市場：最終用途估計與趨勢分析

  • 全球精準醫學市場：最終用途儀表板
  • 全球精準醫療市場：最終用途變異分析
  • 全球精準醫療市場：依最終用途、按收益
  • 居家照護
  • 醫院
  • 臨床實驗室
  • 其他

第6章 精準醫療市場：依類別、應用、最終用途和調查方法進行區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • Janssen Global Services, LLC
    • Illumina, Inc.
    • Quest Diagnostics Incorporated
    • 23andMe, Inc.
    • NeoDiagnostix
    • Myriad Genetics
    • Medtronic
    • GE Healthcare
    • Abbott
    • QIAGEN
Product Code: GVR-2-68038-612-7

Precision Medicine Market Growth & Trends:

The global precision medicine market size is expected to reach USD 249.24 billion by 2030 growing at a CAGR of 16.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Trends such as introduction of cost-effective genomic and molecular biology testing methods, increasing prevalence of cancer and rare diseases, and rising use of big data in precision medicine are some of the key factors boosting market growth.

The Human Genome Project introduced some marvelous cutting-edge techniques such as whole genome sequencing and targeted sequencing. These technologies are being used by researchers for the study of genomes and creation of personalized therapies for treatment of various illnesses. Today, the prevalence of diseases in areas such as oncology, immunology, and neurology has rapidly increased across the globe.

Researchers, healthcare professionals, and big pharma and biotech companies are working together to recognize new focused treatments options for the wellbeing of patients. Currently, there are many therapies and drugs under clinical trials for treatment of different types of cancers. Moreover, researchers have also shown an inclination toward development of precision medicines and diagnostics in non-oncologic disease areas.

Apart from therapeutics, the diagnostics field has also witnessed rapid growth in the past few years. The use of next generation sequencing (NGS), biomarkers, companion diagnostics, and esoteric tests can possibly change and affect prescription patterns of pharmaceutical medicines. Personalized medicines have very high chances of becoming a massive success in the next 20 years and have the capacity to treat and cure a few obstinate illnesses, which was not possible before.

Involvement of government and regulatory bodies has played a very important role in the growth of this field. In 2015, the then U.S. government announced the launch of the Precision Medicine Initiative. The following year, China launched the China Precision Medicine Initiative, which is a 15-year project that aims to build the country as a leader in development of precision therapies.

At present, more than 40% of the medications in biotech and pharmaceutical companies' improvement pipeline incorporate biomarkers. The overview likewise recommended that some biopharmaceutical organizations have collaborated and joint their ventures in the past five years and are expected to continue doing so in the coming years. The diagnostic and therapeutic precision medicine market thus holds immense potential and is quickly turning into a fundamental segment of patient care.

Precision Medicine Market Report Highlights:

  • The therapeutics segment led the market in 2023 and is expected to grow at a CAGR of 15.8% over the forecast period.
  • The hospitals segment led the market with a revenue share of 60.0% in 2023. Hospitals provide the ideal setting for personalized medicine due to their comprehensive infrastructure and access to diverse patient populations.
  • The North America precision medicine market accounted for 53.62% share in 2023. PMC report published in 2022 notes that personalized medicines now account for more than one in four drugs approved by the FDA since 2014.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application and End-use outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Precision Medicine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological advancements in next-generation sequencing
      • 3.2.1.2. Expanding portfolio of companion/associated diagnostics
      • 3.2.1.3. Increasing prevalence of cancer & usage of biomarkers for precision medicine cancer therapy
      • 3.2.1.4. Growing healthcare expenditure triggering development of effective precision medicine
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of nonvalue-based precision medicine diagnostics reimbursement policy
      • 3.2.2.2. Lack of proper intellectual property regulations for precision medical technologies
      • 3.2.2.3. Nonstructural development of biomarkers
  • 3.3. Market opportunity analysis
      • 3.3.1.1. Advancements in genomic technologies
  • 3.4. Precision Medicine Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Pricing Analysis
    • 3.4.4. Volume Analysis (Instruments)

Chapter 4. Precision Medicine Market: Application Estimates & Trend Analysis

  • 4.1. Global Precision Medicine Market: Application Dashboard
  • 4.2. Global Precision Medicine Market: Application Movement Analysis
  • 4.3. Global Precision Medicine Market by Application, Revenue
  • 4.4. Diagnostics
    • 4.4.1. Diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Genetic Testing
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Direct to Consumer Tests
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Esoteric Tests
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Therapeutics
    • 4.5.1. Therapeutics market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Pharmaceuticals
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.2. Oncology
      • 4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.3. Respiratory Disease
      • 4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.4. Skin Diseases
      • 4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.5. CNS Disorders
      • 4.5.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.6. Immunology
      • 4.5.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.7. Genetic Diseases
      • 4.5.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.8. Others
      • 4.5.2.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Medical Devices
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Precision Medicine Market: End-use Estimates & Trend Analysis

  • 5.1. Global Precision Medicine Market: End-use Dashboard
  • 5.2. Global Precision Medicine Market: End-use Movement Analysis
  • 5.3. Global Precision Medicine Market by End-use, Revenue
  • 5.4. Home care
    • 5.4.1. Home care market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Hospitals
    • 5.5.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Clinical Laboratories
    • 5.6.1. Clinical Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Precision Medicine Market: Regional Estimates & Trend Analysis by Category, Application, End-use and Methodology

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. F. Hoffmann-La Roche Ltd
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Siemens Healthineers AG
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Janssen Global Services, LLC
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Illumina, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Quest Diagnostics Incorporated
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. 23andMe, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. NeoDiagnostix
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Myriad Genetics
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Medtronic
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. GE Healthcare
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Abbott
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. QIAGEN
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Mexico precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 10 Mexico precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 13 Europe precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Germany precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 15 Germany precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 UK precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 17 UK precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 France precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 19 France precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Italy precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 21 Italy precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Spain precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 23 Spain precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Denmark precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 25 Denmark precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Sweden precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 27 Sweden precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Norway precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 29 Norway precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 China precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 34 China precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Japan precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 36 Japan precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 India precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 38 India precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 40 South Korea precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 42 Australia precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Thailand precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 44 Thailand precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 46 Latin America precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 47 Latin America precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Brazil precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 49 Brazil precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 MEA precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 54 MEA precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 South Africa precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Africa precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 60 UAE precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 62 Kuwait precision medicine market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in Asia Pacific
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Precision medicine market: market outlook
  • Fig. 14 Precision medicine competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Precision medicine market driver impact
  • Fig. 18 Precision medicine market restraint impact
  • Fig. 19 Precision medicine market: Application movement analysis
  • Fig. 20 Precision medicine market: Application outlook and key takeaways
  • Fig. 21 Diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Genetic tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Direct to Consumer Tests estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Esoteric Tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Oncology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Respiratory Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Skin Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 CNS Disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Immunology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Genetic Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Medical Devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Precision medicine market: End-use movement analysis
  • Fig. 38 Precision medicine market: End-use outlook and key takeaways
  • Fig. 39 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Hospitals estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Clinical laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Global precision medicine market: Regional movement analysis
  • Fig. 44 Global precision medicine market: Regional outlook and key takeaways
  • Fig. 45 Global precision medicine market share and leading players
  • Fig. 46 North America, by country
  • Fig. 47 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. key country dynamics
  • Fig. 49 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Canada key country dynamics
  • Fig. 51 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico key country dynamics
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 UK key country dynamics
  • Fig. 56 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Germany key country dynamics
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 France key country dynamics
  • Fig. 60 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Italy key country dynamics
  • Fig. 62 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Spain key country dynamics
  • Fig. 64 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark key country dynamics
  • Fig. 66 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Sweden key country dynamics
  • Fig. 68 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Norway key country dynamics
  • Fig. 70 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 China key country dynamics
  • Fig. 73 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Japan key country dynamics
  • Fig. 75 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 India key country dynamics
  • Fig. 77 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Thailand key country dynamics
  • Fig. 79 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea key country dynamics
  • Fig. 81 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Australia key country dynamics
  • Fig. 83 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Brazil key country dynamics
  • Fig. 86 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Argentina key country dynamics
  • Fig. 88 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 South Africa key country dynamics
  • Fig. 91 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Saudi Arabia key country dynamics
  • Fig. 93 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 UAE key country dynamics
  • Fig. 95 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Kuwait key country dynamics
  • Fig. 97 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Market share of key market players- Precision medicine market